EP Patent

EP0894503B1 — Bioabsorbable marker having radiopaque constituents and method of using same

Assigned to Schneider USA Inc · Expires 2006-12-20 · 19y expired

What this patent protects

A temporary bioabsorbable-radiopaque marker (14) for use on an implantable endoprosthesis (16). The bioabsorbable-radiopaque marker (14) is adapted to be disposed on or adjacent an implantable endoprosthesis (16) in a body lumen (12) for a predetermined amount of time until the b…

USPTO Abstract

A temporary bioabsorbable-radiopaque marker (14) for use on an implantable endoprosthesis (16). The bioabsorbable-radiopaque marker (14) is adapted to be disposed on or adjacent an implantable endoprosthesis (16) in a body lumen (12) for a predetermined amount of time until the bioabsorbable and radiopaque materials are absorbed or dispersed in the body. <IMAGE>

Drugs covered by this patent

Patent Metadata

Patent number
EP0894503B1
Jurisdiction
EP
Classification
Expires
2006-12-20
Drug substance claim
No
Drug product claim
No
Assignee
Schneider USA Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.